Home > Boards > US OTC > Medical - Healthcare > Wize Pharma Inc. (WIZP)

OphthaliX Launches Updated Website to Reflect Proposed Acquisition

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 109
Posts 24,075
Boards Moderated 14
Alias Born 02/07/04
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2020 4:05:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 9:20:44 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/30/2020 5:33:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/9/2020 4:01:03 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 3/5/2020 5:07:49 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/4/2020 4:03:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 4:23:38 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 2:19:05 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 2:17:07 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2020 2:15:45 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/7/2020 4:32:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/6/2020 8:59:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/15/2020 4:28:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/26/2019 4:32:10 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/26/2019 4:31:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/20/2019 9:13:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/17/2019 4:59:27 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 12/13/2019 3:01:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2019 5:23:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/5/2019 5:14:59 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:55:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:25:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:24:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:23:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2019 5:15:40 PM
midastouch017   Tuesday, 07/14/15 03:28:09 PM
Re: None
Post # of 87 
OphthaliX Launches Updated Website to Reflect Proposed Acquisition of I.V.S.
Tuesday 14 July 2015

PETAH TIKVA, Israel, July 14, 2015 /PRNewswire/ -- OphthaliX Inc. (OTCQB: OPLI), a clinical-stage company focused on developing products that treat and improve sight for people living with ophthalmic disorders, and a subsidiary of Can-Fite BioPharma Ltd. (NYSE MKT: CANF), announced today it has launched an updated website, www.ophthaliX.com, to reflect its definitive agreement to acquire Israel-based Improved Vision Systems Ltd. (I.V.S.).

Upon completion of the acquisition of I.V.S., which is subject to the satisfaction of certain closing conditions, OphthaliX's portfolio of products in development will include two medical devices, Glance™, a desktop application, and vView™, wearable virtual reality goggles. These devices are based on breakthrough technologies that aim to diagnose, improve sight and offer therapy for a variety of ocular diseases and eye conditions including age related macular degeneration (AMD), glaucoma, diabetic retinopathy and oculo-motor pathologies.

OphthaliX continues to develop its drug candidate, CF101, a novel first in class small molecule orally bioavailable drug for ophthalmic indications, glaucoma and uveitis.

About OphthaliX Inc.
OphthaliX Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic products for the treatment of ophthalmic disorders.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist